A leading primary care physician and a world-renowned beta cell researcher discuss how understanding the pathophysiology of beta cells will influence a primary care doctor's choice of drug therapies for their patients. (28:39)
Doron Schneider, MD, a leading primary care physician and Jack Leahy, MD, a world-renowned beta cell researcher, discuss the new concepts, current research and therapies. (48:08)
Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (3:56)
Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (2:27)
Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (1:15)
Frequently asked questions for the primary care community, excerpted from a conversation between a leading primary care physician and a world-renowned beta cell researcher. (4:59)
A 55-year old Caucasian woman has been under your care for three years. Eighteen months ago you diagnosed her with type 2 diabetes mellitus (T2DM). She has a history of mild hypertension, hypercholesteremia, and retinopathy.